RNU6-1096P

Across TCGA pan-cancer cohorts, RNU6-1096P RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated RNU6-1096P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU6-1096P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1096P expression acts as an unfavorable survival marker, although some lineages such as KIRC and MESO show a favorable association.

BLCA, STAD, and TGCT are the cancer types where RNU6-1096P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	III,IV	0.126	0.574	<.001	81	view →
STAD	DFS	Tertile	All	0.457	0.581	.008	42	view →
TGCT	OS	Tertile	All	0.534	0.968	<.001	36	view →
LGG	OS	Tertile	All	0.797	0.903	.008	30	view →
THYM	DFS	Tertile	All	0.563	0.908	.013	27	view →
KIRP	DFS	Tertile	All	0.230	0.629	<.001	21	view →
COAD	DFS	Tertile	IV	0.028	0.496	<.001	18	view →
UCS	OS	Tertile	All	0.185	0.686	.034	18	view →
OV	DFS	Tertile	IV	0.158	0.469	.021	18	view →
READ	DFS	Tertile	IV	0.027	0.636	<.001	18	view →
KIRC	OS	Tertile	All	0.925	0.858	.019	13	view →
SARC	OS	Tertile	All	0.457	0.785	.001	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

RNU6-1096P–BLCA (DFS)

Open the BLCA breakdown →